1. Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study
- Author
-
Mahdi Sheikh, MD, Ramin Shakeri, PhD, Hossein Poustchi, PhD, Akram Pourshams, ProfMD, Arash Etemadi, PhD, Farhad Islami, PhD, Masoud Khoshnia, MD, Abdolsamad Gharavi, MD, Gholamreza Roshandel, PhD, Hooman Khademi, MD, Sadaf G Sepanlou, PhD, Maryam Hashemian, PhD, Abdolreza Fazel, MD, Mahdi Zahedi, MD, Behnoush Abedi-Ardekani, MD, Paolo Boffetta, ProfPhD, Sanford M Dawsey, MD, Paul D Pharoah, ProfPhD, Masoud Sotoudeh, ProfMD, Neal D Freedman, PhD, Christian C Abnet, PhD, Nicholas E Day, ProfPhD, Paul Brennan, PhD, Farin Kamangar, ProfPhD, and Reza Malekzadeh, ProfMD
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: Evidence is emerging for a role of opiates in various cancers. In this study, we aimed to investigate the association between regular opium use and cancer incidence. Methods: This study was done in a population-based cohort of 50 045 individuals aged 40–75 years from northeast Iran. Data on participant demographics, diet, lifestyle, opium use, and different exposures were collected upon enrolment using validated questionnaires. We used proportional hazards regression models to estimate hazard ratios (HRs) and corresponding 95% CIs for the association between opium use and different cancer types. Findings: During a median 10 years of follow-up, 1833 participants were diagnosed with cancer. Use of opium was associated with an increased risk of developing all cancers combined (HR 1·40, 95% CI 1·24–1·58), gastrointestinal cancers (1·31, 1·11–1·55), and respiratory cancers (2·28, 1·58–3·30) in a dose-dependent manner (ptrend
- Published
- 2020
- Full Text
- View/download PDF